← Eichor
Study identifier: NCT06446609 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Drug-induced Liver Injury: Itching Study

Condition: Drug Induced Liver Injury · Pruritus  ·  Sponsor: University of Nottingham

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Idiosyncratic drug-induced liver injury (DILI) is an unpredictable adverse hepatic reaction to a medication used in its therapeutic dose. DILI is the second most common cause of itching in adult Hepatology after biliary obstruction. In particular cholestatic or mixed pattern types of DILI (in which bile flow from the liver is impaired) are associated with long-lasting effects as well as reduced quality of life. There is therefore an urgent need to determine the incidence and natural history of itching in DILI and establish a network of centres that will form a basis for a clinical trial to investigate a novel intervention to treat these.

This description comes directly from the study's public registry record.

Talk to the study team

Elinor Study Coordinator  ·  0115 7484390  ·  Elinor.Cross@nottingham.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Nottingham University Hospitals NHS TrustNottingham, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06446609